9 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25101488	50	Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis.	Bristol-Myers Squibb
23374868	76	1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists.	Chemocentryx
23075267	85	Discovery and lead optimization of a novel series of CC chemokine receptor 1 (CCR1)-selective piperidine antagonists via parallel synthesis.	Bristol-Myers Squibb
22931505	69	Chemokine receptor antagonists.	National Heart and Lung Institute
16198561	99	Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.	Novartis Institutes For Biomedical Research
21036044	43	Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.	Incyte
17446072	68	Structure-activity relationships of novel, highly potent, selective, and orally active CCR1 antagonists.	Tanabe Research Laboratories
11311066	76	Design, synthesis, and discovery of a novel CCR1 antagonist.	Banyu Tsukuba Research Institute In Collaboration With Merck Research Laboratories
30595446	63	Identification of novel azaindazole CCR1 antagonist clinical candidates.	Boehringer Ingelheim Pharmaceuticals